论文部分内容阅读
目的探讨原发性肝癌应用精准肝切除术方案治疗的临床效果。方法选取2014-02-2016-02郑州大学第一附属医院收治240例原发性肝癌患者,采用数字表抽取法随机分组,就精准肝切除术(观察组,n=120)与常规手术(对照组,n=120)效果展开对比。结果观察组选取的原发性肝癌患者实施精准肝切除术,平均出血量明显低于实施常规手术的对照组,差异有统计学意义,P<0.05。观察组仅3例患者输血,输血率占2.5%,对照组输血的患者24例,输血率占20%,差异有统计学意义,P<0.05。观察组手术后第1和7天对ALT检测,均明显高于对照组,差异有统计学意义,P<0.05。观察组仅3例并发症,占2.5%,对照组21例,占17.5%;观察组随访1年,复发6例,占5%,对照组24例,占20%,差异有统计学意义,P<0.05。结论针对临床收治的原发性肝癌病例,采用手术方式治疗,可减少出血,降低输血率,改善肝功能,防范并发症,规避复发事件,对保障患者远期预后价值显著。
Objective To investigate the clinical effect of hepatectomy with primary hepatectomy. Methods 2014-02-2016-02 First Affiliated Hospital of Zhengzhou University, we treated 240 patients with primary hepatocellular carcinoma (HCC) and were randomly divided into three groups based on the digital table extraction method. The patients undergoing precise hepatectomy (observation group, n = 120) Group, n = 120) the effect of contrast. Results In the observation group, the patients with primary liver cancer underwent hepatectomy and the average amount of bleeding was significantly lower than that of the control group undergoing routine surgery, with a significant difference (P <0.05). In the observation group, only 3 patients transfused, the blood transfusion rate accounted for 2.5%, while the control group transfused 24 patients, the transfusion rate was 20%, the difference was statistically significant, P <0.05. The observation group ALT detection 1 and 7 days after surgery were significantly higher than the control group, the difference was statistically significant, P <0.05. The observation group only 3 cases of complications, accounting for 2.5%, 21 cases of control group, accounting for 17.5%; observation group followed up for 1 year, 6 cases of recurrence, accounting for 5%, control group of 24 cases, accounting for 20%, the difference was statistically significant, P <0.05. Conclusion According to the clinical treatment of primary liver cancer cases, surgical treatment can reduce bleeding, reduce blood transfusion rate, improve liver function, prevent complications, avoid recurrence, and protect the long-term prognosis of patients with significant value.